(secondQuint)Safety and Efficacy Study of a Novel Ointment to Treat Plaque Type Psoriasis.

 This is a multicenter, randomized, double-blind, vehicle-controlled, bilateral design.

 Patients will apply both test article AN2728 Ointment B (0.

5% or 2%), and Ointment B Vehicle twice daily for 12 weeks.

 The assigned study medication will be applied to two comparable treatment targeted plaques identified at baseline.

 One test article will be applied to one plaque and the other test article to an anatomically distinct plaque.

 All efficacy evaluations will be measured from only the two plaques identified at the baseline visit.

.

 Safety and Efficacy Study of a Novel Ointment to Treat Plaque Type Psoriasis@highlight

The purpose of this study is to evaluate the safety and efficacy of AN2728 Ointment B, 2.

0% and 0.

5%, compared to Ointment Vehicle B, applied once or twice daily for 12 weeks, in the treatment of plaque type psoriasis